Technical Analysis for SPHS - Sophiris Bio, Inc.
|Grade||Last Price||% Change||Price Change|
SPHS closed up 1.89 percent on Wednesday, January 16, 2019, on 45 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
|See historical SPHS trend table...|
|Date||Alert Name||Type||% Chg|
|Jan 16||1,2,3 Retracement Bearish||Bearish Swing Setup||0.00%|
|Jan 16||Boomer Sell Setup||Bearish Swing Setup||0.00%|
|Jan 16||Non-ADX 1,2,3,4 Bearish||Bearish Swing Setup||0.00%|
|Jan 16||Narrow Range Bar||Range Contraction||0.00%|
|Jan 16||NR7||Range Contraction||0.00%|
|Jan 16||Inside Day||Range Contraction||0.00%|
|Jan 16||Wide Bands||Range Expansion||0.00%|
|Jan 15||Wide Bands||Range Expansion||1.89%|
|Jan 14||Crossed Above 20 DMA||Bullish||-1.82%|
|Jan 14||Wide Bands||Range Expansion||-1.82%|
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicatorsBasic chart:
Sophiris Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the research, development, and commercialization of products for the treatment of urological diseases. Its primary product candidate includes PRX302, which has completed a Phase IIb clinical trial for treatment for the symptoms of benign prostatic hyperplasia, as well as for the treatment of prostate cancer. The company was formerly known as Protox Therapeutics Inc. and changed its name to Sophiris Bio, Inc. in April 2012. Sophiris Bio, Inc. is headquartered in La Jolla, California.
|Indicator||Bull Case||Neutral / Hold||Bear Case|
|Oversold / Overbought|
|Summary:||Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.|
See more SPHS news...
|52 Week High||4.05|
|52 Week Low||0.75|
|200-Day Moving Average||2.5151|
|50-Day Moving Average||1.5836|
|20-Day Moving Average||0.9739|
|10-Day Moving Average||1.0705|
|Average True Range||0.1373|
|Chandelier Exit (Long, 3 ATRs )||1.7481|
|Chandelier Exit (Short, 3 ATRs )||1.1619|
|Upper Bollinger Band||1.2277|
|Lower Bollinger Band||0.7201|
|Percent B (%b)||0.71|
|MACD Signal Line||-0.2004|
|Market Cap||32.52 Million|
|Num Shares||30.1 Million|
|Price-to-Earnings (P/E) Ratio||-4.50|
|Pivot Point Level||Traditional / Classic||Fibonacci||Demark||Woodie||Camarilla|
|Resistance 4 (R4)||1.14|
|Resistance 3 (R3)||1.14||1.11||1.13|
|Resistance 2 (R2)||1.11||1.10||1.12||1.13|
|Resistance 1 (R1)||1.10||1.09||1.11||1.10||1.12|
|Support 1 (S1)||1.06||1.06||1.07||1.06||1.04|
|Support 2 (S2)||1.03||1.05||1.04||1.03|
|Support 3 (S3)||1.02||1.03||1.03|
|Support 4 (S4)||1.02|